Nordea Investment Management
TXG icon

Nordea Investment Management’s 10x Genomics TXG Stock Holding History

Nordea Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,312
Closed -$251K – 989
2022
Q1 		$251K Hold
3,312
– – ﹤0.01% 942
2021
Q4 		$509K Hold
3,312
– – ﹤0.01% 917
2021
Q3 		$490K Hold
3,312
– – ﹤0.01% 925
2021
Q2 		$649K Hold
3,312
– – ﹤0.01% 880
2021
Q1 		$588K Hold
3,312
– – ﹤0.01% 876
2020
Q4 		$469K Buy
+3,312
New +$481K ﹤0.01% 867

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Nordea Investment Management's TXG Position: Q2 2022 in Review

Nordea Investment Management sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 3,312 shares — an estimated $251K sold.

Nordea Investment Management first reported a position in TXG in Q4 2020 and held it in 6 quarters. The position peaked at $649K in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Nordea Investment Management reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Nordea Investment Management sold 3,312 10x Genomics shares in Q2 2022, an estimated $251K.
  • Nordea Investment Management first reported a position in 10x Genomics in Q4 2020 and held it in 6 quarters.
  • Nordea Investment Management's 10x Genomics position peaked at $649K in Q2 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Nordea Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.